Gammabulin
Every registration of this product has been cancelled.
No structure available
This product's active ingredient could not be matched to a single known compound.
Registration
- Applicants
- 1
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock Ingram Critical Care (Pty) LtdCancelled | Gammabulin | 2 ml, 5 ml, 10 ml | 290262, 290263, 290264 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Gammabulin 2 ML EACH 2,0 ml SOLUTION CONTAINS IMMUNOGLOBULIN HUMAN NORMAL 320,0 mg | 2 ml | 29026229/30.3/0262 | Cancelled | Not determined | None |
| Gammabulin 5 ML EACH 5,0 ml SOLUTION CONTAINS IMMUNOGLOBULIN HUMAN NORMAL 800,0 mg | 5 ml | 29026329/30.3/0263 | Cancelled | Not determined | None |
| Gammabulin 10 ML EACH 10,0 ml SOLUTION CONTAINS IMMUNOGLOBULIN HUMAN NORMAL 1600,0 mg | 10 ml | 29026429/30.3/0264 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.